Allele-specific differences in activity of a novel cannabinoid receptor 1 (CNR1) gene intronic enhancer in hypothalamus, dorsal root ganglia, and hippocampus

Journal of Biological Chemistry

Volumn 287, Issue 16, 2012, Pages 12828-12834

  Nicoll, Gemma ^a   Davidson, Scott ^a   Shanley, Lynne ^a   Hing, Ben ^a   Lear, Marissa ^a   McGuffin, Peter ^b   Ross, Ruth ^a   MacKenzie, Alasdair ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN VOLUME; CANNABINOID RECEPTORS; CHRONIC INFLAMMATORY; COMPARATIVE GENOMICS; DORSAL ROOT GANGLIA; HIPPOCAMPAL CELLS; INTRONIC ENHANCER; LINKAGE DISEQUILIBRIUM; MAPK SIGNALING; SCHIZOPHRENIA PATIENTS; WHITE MATTER;

DNA SEQUENCES; NUTRITION;

GENES;

CANNABIS; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE;

ADDICTION; ALLELE; ANIMAL CELL; ARTICLE; BRAIN ATROPHY; BRAIN NERVE CELL; CANNABINOID RECEPTOR 1 GENE; COMPARATIVE STUDY; CONTROLLED STUDY; ENHANCER REGION; ENZYME ACTIVATION; GENE; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENOMICS; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS; INTRON; NERVE CELL; NEWBORN; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SPINAL GANGLION; WHITE MATTER;

ALLELES; ANIMALS; BASE SEQUENCE; CHICKENS; CHRONIC PAIN; CONSERVED SEQUENCE; ENHANCER ELEMENTS, GENETIC; GANGLIA, SPINAL; HIPPOCAMPUS; HUMANS; HYPOTHALAMUS; INTRONS; LINKAGE DISEQUILIBRIUM; MAP KINASE SIGNALING SYSTEM; MOLECULAR SEQUENCE DATA; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PRIMARY CELL CULTURE; RATS; RECEPTOR, CANNABINOID, CB1; SCHIZOPHRENIA; SPECIES SPECIFICITY;

CANNABIS;

EID: 84859755509     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.336750     Document Type: Article

References (53)

1. Iversen, L. (2003) Cannabis and the brain. Brain 126, 1252-1270
2. López-Moreno, J. A., González-Cuevas, G., Moreno, G., and Navarro, M. (2008) The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction. Addict. Biol. 13, 160-187 (Pubitemid 351692981)
3. Idelevich, E., Kirch, W., and Schindler, C. (2009) Current pharmacotherapeutic concepts for the treatment of obesity in adults. Ther. Adv. Cardiovasc. Dis. 3, 75-90
4. Akbas, F., Gasteyger, C., Sjödin, A., Astrup, A., and Larsen, T. M. (2009) A critical review of the cannabinoid receptor as a drug target for obesity management. Obes. Rev. 10, 58-67
5. Carr, T. P., Jesch, E. D., and Brown, A. W. (2008) Endocannabinoids, metabolic regulation, and the role of diet. Nutr. Res. 28, 641-650
6. Riedel, G., and Davies, S. N. (2005) Cannabinoid function in learning, memory, and plasticity. Handb. Exp. Pharmacol. 445-477
7. Wilson, R. I., and Nicoll, R. A. (2002) Endocannabinoid signaling in the brain. Science 296, 678-682
8. Pertwee, R. G. (1999) Cannabis and cannabinoids: pharmacology and rationale for clinical use. Forsch. Komplementarmed. 6, Suppl. 3, 12-15
9. Talwar, R., and Potluri, V. K. (2011) Cannabinoid 1 (CB1) receptor: pharmacology, role in pain, and recent developments in emerging CB1 agonists. CNS Neurol. Disord. Drug Targets 10, 536-544
10. Ehlers, C. L., Slutske, W. S., Lind, P. A., and Wilhelmsen, K. C. (2007) Association between single nucleotide polymorphisms in the cannabinoid receptor gene (CNR1) and impulsivity in southwest California Indians. Twin Res. Hum. Genet. 10, 805-811 (Pubitemid 350292293)
11. Benzinou, M., Chèvre, J. C., Ward, K. J., Lecoeur, C., Dina, C., Lobbens, S., Durand, E., Delplanque, J., Horber, F. F., Heude, B., Balkau, B., Borch- Johnsen, K., Jørgensen, T., Hansen, T., Pedersen, O., Meyre, D., and Froguel, P. (2008) Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations. Hum. Mol. Genet. 17, 1916-1921 (Pubitemid 351865840)
12. Chen, X., Williamson, V. S., An, S. S., Hettema, J. M., Aggen, S. H., Neale, M. C., and Kendler, K. S. (2008) Cannabinoid receptor 1 gene association with nicotine dependence. Arch. Gen. Psychiatry 65, 816-824 (Pubitemid 351957707)
13. Hutchison, K. E., Haughey, H., Niculescu, M., Schacht, J., Kaiser, A., Stitzel, J., Horton, W. J., and Filbey, F. (2008) The incentive salience of alcohol: translating the effects of genetic variant in CNR1. Arch. Gen. Psychiatry 65, 841-850 (Pubitemid 351957709)
14. Haughey, H. M., Marshall, E., Schacht, J. P., Louis, A., and Hutchison, K. E. (2008) Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes. Addiction 103, 1678-1686
15. Filbey, F. M., Schacht, J. P., Myers, U. S., Chavez, R. S., and Hutchison, K. E. (2010) Individual and additive effects of the CNR1 and FAAH genes on brain response to marijuana cues. Neuropsychopharmacology 35, 967-975
16. Dinu, I. R., Popa, S., Bîcu, M., Moţa, E., and Moţa, M. (2009) The implication of CNR1 gene's polymorphisms in the modulation of endocannabinoid system effects. Rom. J. Intern. Med. 47, 9-18
17. Ho, B. C., Wassink, T. H., Ziebell, S., and Andreasen, N. C. (2011) Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia. Schizophr. Res. 128, 66-75
18. Matys, V., Fricke, E., Geffers, R., Gössling, E., Haubrock, M., Hehl, R., Hornischer, K., Karas, D., Kel, A. E., Kel-Margoulis, O. V., Kloos, D. U., Land, S., Lewicki-Potapov, B., Michael, H., Münch, R., Reuter, I., Rotert, S., Saxel, H., Scheer, M., Thiele, S., and Wingender, E. (2003) TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res. 31, 374-378 (Pubitemid 36150406)
19. Shanley, L., Davidson, S., Lear, M., Thotakura, A. K., McEwan, I. J., Ross, R. A., and MacKenzie, A. (2010) Long-range regulatory synergy is required to allow control of the TAC1 locus by MEK/ERK signaling in sensory neurons. Neurosignals 18, 173-185
20. Shanley, L., Lear, M., Davidson, S., Ross, R., and MacKenzie, A. (2011) Evidence for regulatory diversity and auto-regulation at the TAC1 locus in sensory neurons. J. Neuroinflammation 8, 10
21. Vanheusden, K., Mulder, C. L., van der Ende, J., Selten, J. P., van Lenthe, F. J., Verhulst, F. C., and Mackenbach, J. P. (2008) Associations between ethnicity and self-reported hallucinations in a population sample of young adults in The Netherlands. Psychol. Med. 38, 1095-1102 (Pubitemid 351950149)
22. Davidson, S., Miller, K. A., Dowell, A., Gildea, A., and Mackenzie, A. (2006) A remote and highly conserved enhancer supports amygdala-specific expression of the gene encoding the anxiogenic neuropeptide substance- P. Mol. Psychiatry 11, 410-421
23. Davidson, S., Starkey, A., and MacKenzie, A. (2009) Evidence of uneven selective pressure on different subsets of the conserved human genome: implications for the significance of intronic and intergenic DNA. BMC Genomics 10, 614
24. MacKenzie, A. (2010) GWA studies, gene regulation, and disease: pointers for the future of medical science? in Projects, Insight Publishers, http://www.projectsmagazine.eu.com/opinion/gwa-studies-gene-regulation-and- disease
25. Mackenzie, A., Miller, K. A., and Collinson, J. M. (2004) Is there a functional link between gene interdigitation and multispecies conservation of synteny blocks? Bioessays 26, 1217-1224 (Pubitemid 39536617)
26. MacKenzie, A., Payne, C., Boyle, S., Clarke, A. R., and Quinn, J. P. (2000) The human preprotachykinin-A gene promoter has been highly conserved and can drive human-like marker gene expression in the adult mouse CNS. Mol. Cell. Neurosci. 16, 620-630 (Pubitemid 32001310)
27. MacKenzie, A., Purdie, L., Davidson, D., Collinson, M., and Hill, R. E. (1997) Two enhancer domains control early aspects of the complex expression pattern of Msx1. Mech. Dev. 62, 29-40 (Pubitemid 27165377)
28. Miller, K. A., Barrow, J., Collinson, J. M., Davidson, S., Lear, M., Hill, R. E., and Mackenzie, A. (2007) A highly conserved Wnt-dependent TCF4 binding site within the proximal enhancer of the anti-myogenic Msx1 gene supports expression within Pax3-expressing limb bud muscle precursor cells. Dev. Biol. 311, 665-678 (Pubitemid 350046522)
29. Miller, K. A., Davidson, S., Liaros, A., Barrow, J., Lear, M., Heine, D., Hoppler, S., and MacKenzie, A. (2008) Prediction and characterization of a highly conserved, remote, and cAMP-responsive enhancer that regulates Msx1 gene expression in cardiac neural crest and outflow tract. Dev. Biol. 317, 686-694
30. Davidson, S., Lear, M., Shanley, L., Hing, B., Baizan-Edge, A., Herwig, A., Quinn, J. P., Breen, G., McGuffin, P., Starkey, A., Barrett, P., and MacKenzie, A. (2011) Differential activity by polymorphic variants of a remote enhancer that supports galanin expression in the hypothalamus and amygdala: implications for obesity, depression, and alcoholism. Neuropsychopharmacology 36, 2211-2221
31. Takahashi, E., and Berk, B. C. (1998) MAP kinases and vascular smooth muscle function. Acta Physiol. Scand. 164, 611-621 (Pubitemid 29015679)
32. Schmitz, U., and Berk, B. C. (1997) Angiotensin II signal transduction: stimulation of multiple mitogen-activated protein kinase pathways. Trends Endocrinol. Metab. 8, 261-266 (Pubitemid 27424202)
33. Wolf, G., and Ziyadeh, F. N. (1997) Renal tubular hypertrophy induced by angiotensin II. Semin. Nephrol. 17, 448-454 (Pubitemid 27398457)
34. Hipskind, R. A., and Bilbe, G. (1998) MAP kinase signaling cascades and gene expression in osteoblasts. Front. Biosci. 3, d804-816
35. Jo, Y. H., Chen, Y. J., Chua, S. C., Jr., Talmage, D. A., and Role, L. W. (2005) Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit. Neuron 48, 1055-1066 (Pubitemid 41814707)
36. Kawasaki, Y., Kohno, T., and Ji, R. R. (2006) Different effects of opioid and cannabinoid receptor agonists on C-fiber-induced extracellular signal-regulated kinase activation in dorsal horn neurons in normal and spinal nerve-ligated rats. J. Pharmacol. Exp. Ther. 316, 601-607 (Pubitemid 43130986)
37. Turu, G., and Hunyady, L. (2010) Signal transduction of the CB1 cannabinoid receptor. J. Mol. Endocrinol. 44, 75-85
38. Graham, E. S., Ball, N., Scotter, E. L., Narayan, P., Dragunow, M., and Glass, M. (2006) Induction of Krox-24 by endogenous cannabinoid type 1 receptors in Neuro2A cells is mediated by the MEK-ERK MAPK pathway and is suppressed by the phosphatidylinositol 3-kinase pathway. J. Biol. Chem. 281, 29085-29095 (Pubitemid 44507052)
39. Karanian, D. A., Brown, Q. B., Makriyannis, A., and Bahr, B. A. (2005) Blocking cannabinoid activation of FAK and ERK1/2 compromises synaptic integrity in hippocampus. Eur. J. Pharmacol. 508, 47-56 (Pubitemid 40169901)
40. Roth, T. L., and Sweatt, J. D. (2008) Rhythms of memory. Nat. Neurosci. 11, 993-994
41. Miyamoto, E. (2006) Molecular mechanism of neuronal plasticity: induction and maintenance of long-term potentiation in the hippocampus. J. Pharmacol. Sci. 100, 433-442
42. Waltereit, R., and Weller, M. (2003) Signaling from cAMP/PKA to MAPK and synaptic plasticity. Mol. Neurobiol. 27, 99-106 (Pubitemid 36515162)
43. Kristensen, F. W. (1994) [Cannabis and psychoses]. Ugeskr. Laeger 156, 2875-2878, 2881
44. Port, R. L., and Seybold, K. S. (1995) Hippocampal synaptic plasticity as a biological substrate underlying episodic psychosis. Biol. Psychiatry 37, 318-324
45. Ashtari, M., Avants, B., Cyckowski, L., Cervellione, K. L., Roofeh, D., Cook, P., Gee, J., Sevy, S., and Kumra, S. (2011) Medial temporal structures and memory functions in adolescents with heavy cannabis use. J. Psychiatr Res. 45, 1055-1066
46. Breivogel, C. S., Sim, L. J., and Childers, S. R. (1997) Regional differences in cannabinoid receptor/G-protein coupling in rat brain. J. Pharmacol. Exp. Ther. 282, 1632-1642 (Pubitemid 27408350)
47. Rubino, T., Forlani, G., Viganò, D., Zippel, R., and Parolaro, D. (2005) Ras/ERK signaling in cannabinoid tolerance: from behavior to cellular aspects. J. Neurochem. 93, 984-991 (Pubitemid 40695757)
48. Henquet, C., Di Forti, M., Morrison, P., Kuepper, R., and Murray, R. M. (2008) Gene-environment interplay between cannabis and psychosis. Schizophr. Bull. 34, 1111-1121
49. Moore, J. H., Asselbergs, F. W., and Williams, S. M. (2010) Bioinformatics challenges for genome-wide association studies. Bioinformatics 26, 445-455
50. Touw, M. (1981) The religious and medicinal uses of cannabis in China, India, and Tibet. J. Psychoactive Drugs 13, 23-34
51. Zolkowska, K., Cantor-Graae, E., and McNeil, T. F. (2001) Increased rates of psychosis among immigrants to Sweden: is migration a risk factor for psychosis? Psychol. Med. 31, 669-678 (Pubitemid 32421968)
52. Reeves, S. J., Sauer, J., Stewart, R., Granger, A., and Howard, R. J. (2001) Increased first-contact rates for very-late-onset schizophrenia-like psychosis in African- and Caribbean-born elders. Br. J. Psychiatry 179, 172-174 (Pubitemid 32756501)
53. Veling, W., Selten, J. P., Susser, E., Laan, W., Mackenbach, J. P., and Hoek, H. W. (2007) Discrimination and the incidence of psychotic disorders among ethnic minorities in The Netherlands. Int. J. Epidemiol. 36, 761-768 (Pubitemid 47394141)